Moloney Securities Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,547
Closed -$313K 442
2022
Q4
$313K Sell
1,547
-287
-16% -$56.1K 0.07% 280
2022
Q3
$323K Sell
1,834
-30
-2% -$6.14K 0.08% 258
2022
Q2
$375K Sell
1,864
-322
-15% -$68.6K 0.09% 241
2022
Q1
$495K Sell
2,186
-352
-14% -$82.8K 0.1% 223
2021
Q4
$685K Sell
2,538
-89
-3% -$22K 0.12% 202
2021
Q3
$635K Sell
2,627
-165
-6% -$41.6K 0.12% 213
2021
Q2
$662K Sell
2,792
-265
-9% -$60.4K 0.12% 208
2021
Q1
$670K Buy
3,057
+233
+8% +$46.8K 0.13% 183
2020
Q4
$494K Sell
2,824
-35
-1% -$6.04K 0.11% 206
2020
Q3
$462K Buy
2,859
+744
+35% +$118K 0.12% 181
2020
Q2
$302K Buy
+2,115
New +$293K 0.09% 225

Other funds holding LH

Moloney Securities Asset Management's LH Position: Q1 2023 in Review

Moloney Securities Asset Management sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,547 shares — an estimated $313K sold.

Moloney Securities Asset Management first reported a position in LH in Q2 2020 and held it in 11 quarters. The position peaked at $685K in Q4 2021. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Moloney Securities Asset Management reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Moloney Securities Asset Management sold 1,547 Labcorp shares in Q1 2023, an estimated $313K.
  • Moloney Securities Asset Management first reported a position in Labcorp in Q2 2020 and held it in 11 quarters.
  • Moloney Securities Asset Management's Labcorp position peaked at $685K in Q4 2021.
  • 940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Moloney Securities Asset Management's 13F filing for Q1 2023, filed 12 May 2023.